Product Information
AZD0424 is a potent, selective and orally bioavailable HER2 inhibitor. It has been shown to inhibit the proliferation of human breast cancer cells in vitro and in vivo. AZD0424 is currently being investigated for the treatment of HER2+ metastatic breast cancer, with promising results in early clinical trials. It also inhibits tumor growth and metastasis in colorectal cancer patients who have received chemotherapy but are resistant to cisplatin treatment. AZD0424 has been shown to have an anti-tumor effect on solid tumour cells, inhibiting cellular transformation and tumor growth by blocking epidermal growth factor receptor activation.
Chemical properties
Technical inquiry about: 3D-SCB05406 AZD0424
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
